Table 1.
Demographic data of study patients.
| Patient 1 | Patient 2 | Patient 3 | |
|---|---|---|---|
| Age | 64 | 56 | 59 |
| Menopause status | Postmenopausal | Postmenopausal | Postmenopausal |
| BMI (kg/m²) | 34.0 | 19.5 | 27.9 |
| Smoking history | None | None | None |
| BMD (t-score) | −1.9 [L1–L2] | −1.3 [L1–L4] | −2.2 [L1–L4] |
| Breast cancer | Metastatic to soft tissues | Extensive bone metastases | Limited bone metastases |
| Current therapy | Aromatase inhibitor | Aromatase inhibitor | Aromatase inhibitor |
| Bisphosphonate use and duration | Nil | Yes (3 years) | Yes (2 years) |
BMI=body mass index, BMD= bone mineral density and L=lumbar spine (i.e. L1=first lumbar vertebrae).